Altimmune Files 8-K with Corporate Updates

Ticker: ALT · Form: 8-K · Filed: Apr 16, 2026

Sentiment: neutral

Topics: corporate-governance, filing, bylaws

TL;DR

ALT files 8-K: corporate docs updated, shareholder votes, and financials. Nothing major, just housekeeping.

AI Summary

Altimmune, Inc. filed an 8-K on April 16, 2026, reporting amendments to its articles of incorporation or bylaws, submission of matters to a vote of security holders, and financial statements and exhibits. The filing includes exhibits such as the company's 8-K filing itself and related XBRL data.

Why It Matters

This filing indicates corporate governance updates and potential shareholder votes, which are important for investors to understand the company's operational and structural changes.

Risk Assessment

Risk Level: low — The filing is primarily procedural and informational, with no immediate financial or operational risks indicated.

Key Numbers

Key Players & Entities

FAQ

What specific items were amended in Altimmune's articles of incorporation or bylaws?

The filing indicates Item 5.03 covers Amendments to Articles of Incorporation or Bylaws, but the specific details of the amendments are not provided in the summary text.

What matters were submitted to a vote of security holders?

Item 5.07 of the filing pertains to the Submission of Matters to a Vote of Security Holders, however, the specific matters are not detailed in the provided text.

What types of financial statements and exhibits are included in the filing?

Item 9.01 covers Financial Statements and Exhibits, and the filing lists the 8-K document itself and XBRL-related files as exhibits.

When was this 8-K filing accepted by the SEC?

The filing was accepted on 2026-04-16 at 17:07:34.

What is Altimmune, Inc.'s state of incorporation?

Altimmune, Inc. is incorporated in Delaware (DE).

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on April 16, 2026 regarding Altimmune, Inc. (ALT).

View full filing on EDGAR

View on Read The Filing